● Citizens reported continued growth in its insuranceBusinessin its second-quarter 2026 results, including higher insurance-in-force and net income.
● Collegium reported second-quarter 2026Revenueof about $199.9 million, with its ADHD portfolio surging.
● Citius reported LYMPHIR productRevenueof about $1.49 million in its fiscal third-quarter 2026 results, with the product now available at 44 oncology centers.
● Equifax reported second-quarter 2026Revenuegrowth of about 11%, beating estimates, driven by strength in U.S. Information Solutions and mortgage-related businesses.
● Advantage Solutions reported second-quarter 2026Revenuegrowth of about 1.8% year over year, beating revenue estimates.
● Gibraltar reported second-quarter 2026 net sales of about $509.5 million, up 64.6% year over year, driven primarily by its OmniMax acquisition.
● Varonis reported second-quarter 2026 SaaS annualRecurring Revenueof about $726 million, up about 52% year over year, with total ARR of about $742 million, up about 18%.
● Waystar reported second-quarter 2026Revenueof about $319.7 million, up 18% year over year, withNet Incomeof about $40.9 million.
● GeneDx reported second-quarter 2026Revenueof about $114.4 million, up 11% year over year, with record test volume.
● PDD reported second-quarter 2026Revenuegrowth alongside a net-profit decline of about 12%, though results beat expectations.